Meihua International Medical Technologies Co Ltd
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-dens… Read more
Meihua International Medical Technologies Co Ltd (MHUA) - Net Assets
Latest net assets as of June 2025: $164.95 Million USD
Based on the latest financial reports, Meihua International Medical Technologies Co Ltd (MHUA) has net assets worth $164.95 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($190.58 Million) and total liabilities ($25.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $164.95 Million |
| % of Total Assets | 86.55% |
| Annual Growth Rate | 23.65% |
| 5-Year Change | 87.61% |
| 10-Year Change | N/A |
| Growth Volatility | 13.18 |
Meihua International Medical Technologies Co Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Meihua International Medical Technologies Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Meihua International Medical Technologies Co Ltd (2018–2024)
The table below shows the annual net assets of Meihua International Medical Technologies Co Ltd from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $158.98 Million | +8.27% |
| 2023-12-31 | $146.84 Million | +5.88% |
| 2022-12-31 | $138.68 Million | +29.84% |
| 2021-12-31 | $106.81 Million | +26.05% |
| 2020-12-31 | $84.74 Million | +42.04% |
| 2019-12-31 | $59.66 Million | +34.18% |
| 2018-12-31 | $44.46 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Meihua International Medical Technologies Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 181.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $105.23 Million | 66.19% |
| Common Stock | $15.95K | 0.01% |
| Other Comprehensive Income | $4.71 Million | 2.96% |
| Other Components | $49.02 Million | 30.84% |
| Total Equity | $158.98 Million | 100.00% |
Meihua International Medical Technologies Co Ltd Competitors by Market Cap
The table below lists competitors of Meihua International Medical Technologies Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Prospech Ltd
AU:PRS
|
$2.24 Million |
|
Kardan Israel Ltd
TA:KRDI
|
$2.24 Million |
|
Vineet Laboratories Limited
NSE:VINEETLAB
|
$2.24 Million |
|
Inomin Mines Inc
V:MINE
|
$2.24 Million |
|
GENMAB (GE9.SG)
STU:GE9
|
$2.24 Million |
|
Tangelo Games Corp
V:GEL
|
$2.24 Million |
|
BCB Bhd
KLSE:6602
|
$2.24 Million |
|
Korporacja Gospodarcza efekt S.A
WAR:EFK
|
$2.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Meihua International Medical Technologies Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 146,331,840 to 158,975,547, a change of 12,643,707 (8.6%).
- Net income of 10,843,589 contributed positively to equity growth.
- Share repurchases of 200,000 reduced equity.
- Other comprehensive income decreased equity by 4,005,523.
- Other factors increased equity by 6,005,641.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $10.84 Million | +6.82% |
| Share Repurchases | $200.00K | -0.13% |
| Other Comprehensive Income | $-4.01 Million | -2.52% |
| Other Changes | $6.01 Million | +3.78% |
| Total Change | $- | 8.64% |
Book Value vs Market Value Analysis
This analysis compares Meihua International Medical Technologies Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $222.31 | $9.90 | x |
| 2019-12-31 | $247.13 | $9.90 | x |
| 2020-12-31 | $351.02 | $9.90 | x |
| 2021-12-31 | $5.34 | $9.90 | x |
| 2022-12-31 | $589.99 | $9.90 | x |
| 2023-12-31 | $611.24 | $9.90 | x |
| 2024-12-31 | $580.80 | $9.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Meihua International Medical Technologies Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.82%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.19%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.17x
- Recent ROE (6.82%) is below the historical average (17.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 34.81% | 20.44% | 1.21x | 1.40x | $11.03 Million |
| 2019 | 25.87% | 19.38% | 1.09x | 1.23x | $9.47 Million |
| 2020 | 22.48% | 21.38% | 0.84x | 1.25x | $10.57 Million |
| 2021 | 18.72% | 19.22% | 0.76x | 1.28x | $9.31 Million |
| 2022 | 4.52% | 6.04% | 0.63x | 1.18x | $-7.57 Million |
| 2023 | 7.94% | 11.97% | 0.56x | 1.17x | $-3.01 Million |
| 2024 | 6.82% | 11.19% | 0.52x | 1.17x | $-5.05 Million |
Industry Comparison
This section compares Meihua International Medical Technologies Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Meihua International Medical Technologies Co Ltd (MHUA) | $164.95 Million | 34.81% | 0.16x | $2.24 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |